Advances in male contraception.

作者: Stephanie T. Page , John K. Amory , William J. Bremner

DOI: 10.1210/ER.2007-0041

关键词:

摘要: Despite significant advances in contraceptive options for women over the last 50 yr, world population continues to grow rapidly. Scientists and activists alike point devastating environmental impacts that pressures have caused, including global warming from developed hunger disease less areas. Moreover, almost half of all pregnancies are still unwanted or unplanned. Clearly, there is a need expanded, reversible, options. Multicultural surveys demonstrate willingness men participate contraception their female partners trust them do so. Notwithstanding paucity options, male methods vasectomy condoms account one third use United States other countries. Recent international clinical research efforts demonstrated high efficacy rates (90–95%) hormonally based contraceptives. Current barriers expanded include limited delivery perceived regulatory obstacles, which stymie introduction marketplace. However, oral injectable androgen cause optimism these hurdles may be overcome. Nonhormonal methods, such as compounds target sperm motility, attractive theoretical promise specificity reproductive tract. Gene protein array technologies continue identify potential targets this approach. Such nonhormonal agents will likely reach trials near future. Great strides been made understanding physiology; combined scientists, clinicians, industry governmental funding agencies could make an effective, option family planning next decade.

参考文章(432)
T. T. Turner, L. L. Ewing, C. E. Jones, S. S. Howards, B. Zegeye, Androgens in male rat reproductive tract fluids: hypophysectomy and steroid replacement. American Journal of Physiology-endocrinology and Metabolism. ,vol. 248, ,(1985) , 10.1152/AJPENDO.1985.248.3.E274
John M. Bennett, Paul Dassow, Vasectomy: an update American Family Physician. ,vol. 74, pp. 2069- 2074 ,(2006)
Haishan Fu, Jacqueline E. Darroch, Taylor Haas, Nalini Ranjit, Contraceptive Failure Rates: New Estimates from the 1995 National Survey of Family Growth Family Planning Perspectives. ,vol. 31, pp. 56- 63 ,(1999) , 10.2307/2991640
Joyce C. Abma, Gladys M. Martinez, William D. Mosher, Stephanie J. Willson, Anjani Chandra, Use of contraception and use of family planning services in the United States: 1982-2002. Advance data. pp. 1- 36 ,(2004)
S. J. Segal, Zheng-Xing Chen, Yong-Zhi Tan, Ren-An Zhang, Lin Cao, Yi-Xin Wang, Gen-Di You, Bai-Yong Mao, Zhi-Ping Gu, Low dose gossypol for male contraception. Asian Journal of Andrology. ,vol. 2, pp. 283- 287 ,(2000)
Axel Kamischke, Julia Diebäcker, Eberhard Nieschlag, Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal function Clinical Endocrinology. ,vol. 53, pp. 351- 358 ,(2001) , 10.1046/J.1365-2265.2000.01097.X
William J. Bremner, Yu‐Gui Cui, Yi‐Qun Gu, Gui‐Yuan Zhang, Xing‐Hai Wang, A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men Journal of Andrology. ,vol. 19, pp. 761- 768 ,(1998) , 10.1002/J.1939-4640.1998.TB02086.X
Helen H.N. Yan, Dolores D. Mruk, C. Yan Cheng, Junction Restructuring and Spermatogenesis: The Biology, Regulation, and Implication in Male Contraceptive Development Current Topics in Developmental Biology. ,vol. 80, pp. 57- 92 ,(2007) , 10.1016/S0070-2153(07)80002-0
Andrea D. Coviello, William J. Bremner, Alvin M. Matsumoto, Karen L. Herbst, John K. Amory, Bradley D. Anawalt, Xiaohua Yan, Terry R. Brown, William W. Wright, Barry R. Zirkin, Jonathan P. Jarow, Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen. Journal of Andrology. ,vol. 25, pp. 931- 938 ,(2004) , 10.1002/J.1939-4640.2004.TB03164.X